<DOC>
	<DOCNO>NCT03058614</DOCNO>
	<brief_summary>This study randomize control study compare use two clinical management strategy nephrostomy tube management follow percutaneous nephrolithotomy ( PCNL ) . The first strategy entail use contrast-enhanced ultrasound ( CEUS ) evaluate renal collecting system ( 1 ) . This new image approach apply ultrasound machine special software combination intraluminal ultrasound contrast agent ( Lumason ) injection , FDA-approved ultrasound contrast agent ( 2 ) . The second strategy nephrostomy tube cap trial combine low dose non-contrast compute tomography ( CT ) scan , one frequently utilized clinical management strategy currently use clinical practice ( 3 ) .</brief_summary>
	<brief_title>Contrast-enhanced Ultrasound Versus CT Scan Kidney Stone Patient Management</brief_title>
	<detailed_description>This multi-center , randomize control study comparing use CEUS CT scan plus capping trial immediately follow PCNL . A total recruitment target 1,046 subject plan participant randomize one two study arm . 1 . Contrast-enhanced ultrasound ( CEUS ) arm : On postoperative day 1 ( unless clinically indicate ) , subject undergo CEUS administration Lumason via pre-placed nephrostomy tube . 2 . Non-contrast CT scan plus cap trial arm : On postoperative day 1 ( unless clinically indicate ) , subject ' pre-placed nephrostomy tube cap undergo low dose non-contrast abdominal CT scan . Subsequently , nephrostomy tube manage base result study treat surgeon . Screening data review determine subject eligibility . Subjects meet inclusion criterion none exclusion criterion enter study . The following investigational regimen use CEUS arm : Experimental Investigation : Lumason 2 mL single dose , repeatable time image need . Subjects expose randomization schema 1 day undergo one two diagnostic imaging pathway . After image study complete , clinical care proceed per norm . Clinical image data prospectively collect time initial presentation 6 month surgery . The total duration study expect 5 year reach target accrual . Therefore , investigator anticipate total duration study 4 year 6 month patient recruitment final 6 month use collect follow data .</detailed_description>
	<mesh_term>Kidney Calculi</mesh_term>
	<mesh_term>Nephrolithiasis</mesh_term>
	<criteria>Age 18 year old . Renal and/or ureteral stone size diagnose either ultrasound CT scan require surgical treatment percutaneous removal ( PCNL ) . A second stage PCNL plan expect surgery , entail postoperative tube management predetermine . Subjects serious illness likely cause death within next 5 year , exclude significant metabolic derangement might lead adverse surgical outcome . Subjects history hypersensitivity reaction sulfur hexafluoride lipid microsphere component inactive ingredient Lumason Pregnancy , contraindication CT scan ultrasound contrast injection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Contrast-enhanced ultrasound</keyword>
	<keyword>Percutaneous nephrolithotomy</keyword>
</DOC>